BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
2/15/2023 - JBS Appeals National Advertising Division Recommendation to Discontinue “Net Zero” Emissions by 2040 Claims
New York, NY – February 15, 2023 – In a challenge brought by non-profit the Institute for Agriculture and Trade Policy (IATP), the National Advertising Division (NAD) recommended that JBS discontinue claims relating to its goal of achieving “net zero” emissions by 2040.
-
2/02/2023 - National Advertising Division Finds ACCO Brands’ Coronavirus and COVID-19 Elimination Claims Substantiated with Modified Testing Disclosure
New York, NY – February 2, 2023 – Following an inquiry by the National Advertising Division (NAD), ACCO Brands modified the disclosure for a health-related claim that its TruSens Air Purifier is “effective at eliminating 99.9% of the airborne coronavirus or COVID-19” to clarify the material limitations of the claim.
-
2/01/2023 - National Advertising Division Recommends Charter Communications Discontinue or Modify “Leading” Internet Service Provider Claim for Spectrum Internet
New York, NY – February 1, 2023 – The National Advertising Division (NAD) recommended that Charter discontinue or modify the claim that Spectrum is America’s leading internet service provider (ISP). NAD also recommended that Charter discontinue the claim “Advanced WiFi. A better kind of internet” or modify it to avoid conveying a message of superiority over Spectrum’s competitors.
-
1/31/2023 - National Advertising Division Recommends Dyper Modify Biodegradable Claims for Dyper Brand Diapers
New York, NY – January 31, 2023 – In a challenge brought by Kimberly-Clark Corporation, the National Advertising Division (NAD) determined Dyper, Inc. supported claims that certain components of its bamboo viscose diapers are biodegradable but recommended the claim be qualified in certain ways.
-
1/31/2023 - T-Mobile Voluntarily Discontinues “Customer Loyalty 4x Higher than Xfinity” Claim Following National Advertising Division Challenge by Comcast
New York, NY – January 31, 2023 – Comcast originally filed a Fast-Track SWIFT challenge against competitor T-Mobile’s claim that it has “customer loyalty 4 x higher than Xfinity” made in a television commercial promoting T-Mobile’s Home Internet service. The National Advertising Division (NAD) determined that the challenge was not appropriate for SWIFT and Comcast refiled the challenge in Standard Track.
-
1/23/2023 - National Advertising Division Finds Certain Claims for T-Mobile Home Internet Supported; T-Mobile Appeals Determination That Certain Claims Were Unsupported
New York, NY – January 23, 2023 – In a challenge brought by Comcast, the National Advertising Division (NAD) determined that T-Mobile’s advertising provided a reasonable basis for its price lock claim and concluded that other challenged claims did not convey false or misleading messages. However, NAD recommended that T-Mobile discontinue or modify other claims.
-
1/19/2023 - National Advertising Division Recommends Cox Discontinue Implied Superior Reliability Claim for Cox Internet
New York, NY – January 19, 2023 – Acting on a challenge by AT&T Services, Inc., the National Advertising Division (NAD) recommended that Cox Communications, Inc. discontinue advertising that conveys the implied message that internet from competing services is glitchy and unreliable, but Cox Internet is not.
-
1/19/2023 - National Advertising Division Finds Novartis Breast Cancer Drug Claim Supported in Physician-Directed Messaging, But Not in Ads to Consumers
New York, NY – January 19, 2023 – The National Advertising Division (NAD) determined Novartis Pharmaceutical provided a reasonable basis for the claim that its Kisqali breast cancer treatment drug is “The only CDK4/6 inhibitor with statistically significant overall survival proven across 3 phase III trials” when directed to an audience of health care professionals (HCPs). However, NAD recommended that a substantially similar claim in consumer-facing advertising, along with several implied comparative superiority claims, be discontinued.
-
1/12/2023 - National Advertising Division Recommends RhinoSystems Discontinue Limited Claims that Nasal Irrigation Systems Can Help Prevent Viral Illnesses
New York, NY – January 12, 2023 – The National Advertising Division (NAD) examined a number of challenged health-related claims by RhinoSystems, Inc. and found that the challenged packaging claims and many website claims did not convey virus prevention claims. However, NAD recommended that RhinoSystems discontinue certain other health-related claims that appeared in one television and two radio commercials or on the Naväge website.
-
12/22/2022 - Charter Voluntarily Discontinues Certain Spectrum Mobile Comparative Claims Following AT&T’s National Advertising Division Challenge
New York, NY – December 22, 2022 – In a National Advertising Division (NAD) challenge brought by competitor AT&T Services, Inc., Charter Communications, Inc., d/b/a Spectrum, voluntarily discontinued certain comparative speed and reliability claims for its Spectrum Mobile services vs. AT&T Wireless.